Companies Dominating the Microchips in Medicine Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Applied Microarrays Inc.
- RELX Group
- QIAGEN
- Agilent Technologies, Inc.
- INTROMEDIC
- Otsuka America Pharmaceutical, Inc.
- Medtronic Plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Thermo Fisher Scientific, Inc., announced it has acquired Belgium-based PharmaFluidics, a manufacturer of micro-chip-based chromatography columns. The acquisition will enable Thermo Fisher to expand its portfolio of chromatography and mass spectrometry solutions. It will also provide customers with access to advanced technology for analyzing complex samples.
- Medtronic plc has announced Cosmo Pharmaceuticals and NVIDIA are planning to integrate their AI technology into its intelligent endoscopy module, GI Genius. By using AI-assisted technology, physicians will be able to detect potentially cancerous polyps more quickly and accurately, leading to better patient outcomes.
